![Gillian Cannon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 79 632 $ in data 31/05/2026
Gillian M.
Cannon is currently Director at Affibody AB since 2019, Independent Director at Xenon Pharmaceuticals, Inc. since 2023, and Director at Edinburgh Innovations Ltd. since 2020.
Former roles include Independent Director at Corcept Therapeutics, Inc. from 2020 to 2025, President-North American Operations at UCB, Inc. from 2015 to 2017, Vice President-Commercial Operations at Merck BioVentures from 2008 to 2012, President at Alyvant, Inc., and Head-Commercial Innovation at Roivant Sciences, Inc. from 2020 to 2024.
Education includes undergraduate studies at The University of Edinburgh and doctorates from Temple University (Pennsylvania) and Fox School of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/06/2026 | 1.455 ( 0% ) | 79 632 $ | 31/05/2026 | |
| 10/09/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 08/08/2023 |
Affibody AB
 Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Direttore/Membro del Consiglio | 01/01/2019 |
Edinburgh Innovations Ltd.
 Edinburgh Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research support services | Direttore/Membro del Consiglio | 01/01/2020 |
| Società | Posizione | Fine |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Direttore/Membro del Consiglio | 10/10/2025 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Corporate Officer/Principal | 01/04/2024 |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | 01/01/2017 |
Merck BioVentures | Corporate Officer/Principal | 01/01/2012 |
Alyvant, Inc.
 Alyvant, Inc. Part of Roivant Sciences Ltd., Alyvant, Inc. is a biotechnology company that aims to improve the lives of patients by accelerating the development and commercialization of meaningful medicines. The company is based in New York, NY. | Presidente | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Corcept Therapeutics, Inc.
 Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Edinburgh Innovations Ltd.
Edinburgh Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research support services | Commercial Services |
Fox School of Business
 Fox School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck BioVentures | |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Alyvant, Inc.
Alyvant, Inc. Part of Roivant Sciences Ltd., Alyvant, Inc. is a biotechnology company that aims to improve the lives of patients by accelerating the development and commercialization of meaningful medicines. The company is based in New York, NY. |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
